Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

CVS Health Corp. buy Royal Bank of Canada

Start price
€68.36
03.08.23 / 50%
Target price
€83.15
03.08.24
Performance (%)
-21.18%
End price
€53.88
04.08.24
Summary
This prediction ended on 04.08.24 with a price of €53.88. The price of CVS Health Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.18%. Royal_Bank_of_Canada has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. A total of €2.42 was paid as dividends for this prediction. Royal_Bank_of_Canada has 50% into this prediction

CVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.

Performance without dividends (%)
Name 1w 1m 1y
CVS Health Corp. 0.618% 0.618% -14.718%
iShares Core DAX® -3.429% 5.085% 15.455%
iShares Nasdaq 100 -6.121% 0.593% 16.379%
iShares Nikkei 225® -7.364% 5.479% 6.970%
iShares S&P 500 -4.366% 2.019% 18.650%

Comments by Royal_Bank_of_Canada for this prediction

In the thread CVS Health Corp. diskutieren
Prediction Buy
Perf. (%) -21.18%
Target price 83.147
Change
Ends at 03.08.24

CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Royal Bank of Canada from $102.00 to $91.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat

In the thread Trading CVS Health Corp.
Prediction Buy
Perf. (%) -21.18%
Target price 83.147
Change
Ends at 03.08.24

Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten

Current prediction by Royal_Bank_of_Canada for CVS Health Corp.

buy
CVS Health Corp.

Start price
Target price
Perf. (%)
€69.64
08.02.24
€78.03
08.02.25
-23.43%
06.09.24

Stopped prediction by Royal_Bank_of_Canada for CVS Health Corp.

buy
CVS Health Corp.

Start price
Target price
Perf. (%)
€54.06
04.09.24
€61.42
04.09.25
-3.64%
06.09.24

buy
CVS Health Corp.

Start price
Target price
Perf. (%)
€61.74
18.08.23
€83.68
18.08.24
-14.72%
19.08.24